These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 10781623)

  • 21. [Lymphoid myelofibrosis].
    Mauri C
    Minerva Med; 1975 Jul; 66(49):2360-6. PubMed ID: 1143711
    [No Abstract]   [Full Text] [Related]  

  • 22. Polycythaemia after myeloid metaplasia with fibrosis: an unusual sequence.
    Gardais J; Suraniti S; Fressinaud P
    Haematologica; 1992; 77(5):433-4. PubMed ID: 1483596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone marrow angiogenesis and its clinical correlates in myelofibrosis with myeloid metaplasia.
    Arora B; Ho CL; Hoyer JD; Mesa RA; Tefferi A
    Haematologica; 2004 Dec; 89(12):1454-8. PubMed ID: 15590395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prognostic value of bone and bone marrow lesions of primary myeloid metaplasia].
    Chelloul N; Jacquillat C; Brière J; Laval-Jeantet M; Vorhauer-Atlan W
    Nouv Presse Med; 1975 Dec; 4(43):3060-2. PubMed ID: 1223788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Splenectomy after allogeneic haematopoietic stem cell transplantation in patients with primary myelofibrosis.
    Robin M; Espérou H; de Latour RP; Petropoulou AD; Xhaard A; Ribaud P; Socié G
    Br J Haematol; 2010 Sep; 150(6):721-4. PubMed ID: 20618333
    [No Abstract]   [Full Text] [Related]  

  • 26. Evolution of myelofibrosis in chronic idiopathic myelofibrosis as evidenced in sequential bone marrow biopsy specimens.
    Buhr T; Büsche G; Choritz H; Länger F; Kreipe H
    Am J Clin Pathol; 2003 Jan; 119(1):152-8. PubMed ID: 12520711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stem cell transplantation for myelofibrosis: a report from two Canadian centers.
    Daly A; Song K; Nevill T; Nantel S; Toze C; Hogge D; Forrest D; Lavoie J; Sutherland H; Shepherd J; Hasegawa W; Lipton J; Messner H; Kiss T
    Bone Marrow Transplant; 2003 Jul; 32(1):35-40. PubMed ID: 12815476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ectopic medullary hematopoiesis as a cause of ascites in agnogenic myeloid metaplasia. Case report and review of the literature.
    Knobel B; Melamud E; Virag I; Meytes D
    Acta Haematol; 1993; 89(2):104-7. PubMed ID: 8503241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic idiopathic myelofibrosis with myeloid metaplasia presenting as refractory ascites.
    Patra B; Maheshwari A; Chandra J; Aneja S; Agarwal S; Nangia A; Seth A
    Pediatr Blood Cancer; 2010 Jan; 54(1):151-3. PubMed ID: 19785025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correction of recurrent angioedema related to C1 esterase inhibitor deficiency as a secondary event following nonmyeloablative allogeneic stem cell transplantation in a patient with myelofibrosis.
    Kiss TL; Messner HA; Galal A; Lipton J
    Bone Marrow Transplant; 2005 Jan; 35(2):213-4. PubMed ID: 15531899
    [No Abstract]   [Full Text] [Related]  

  • 31. Splenic irradiation in myelofibrosis with myeloid metaplasia: a review.
    Elliott MA; Tefferi A
    Blood Rev; 1999 Sep; 13(3):163-70. PubMed ID: 10527268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of extramedullary haematopoiesis in rabbits with saponin-induced myelofibrosis and myeloid metaplasia.
    Wang JC; Tobin MS
    Br J Haematol; 1982 Jun; 51(2):277-84. PubMed ID: 7082586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The syndrome of idiopathic myelofibrosis. A clinicopathologic review with emphasis on the prognostic variables predicting survival.
    Varki A; Lottenberg R; Griffith R; Reinhard E
    Medicine (Baltimore); 1983 Nov; 62(6):353-71. PubMed ID: 6633248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myelofibrosis with myeloid metaplasia with fatty bone marrow: report of a new case.
    Gerli GC; Gianelli U; Carraro MC; Bestetti A; Marchetti M; Barosi G
    Haematologica; 2001 Aug; 86(8):885-6. PubMed ID: 11524257
    [No Abstract]   [Full Text] [Related]  

  • 36. [Myelofibrosis in patients with chronic myeloid leukemia treated with interferon-alpha].
    Kumas Sotiris ; Semenova EA; Turkina AG; Zakharova AV; Domracheva EV; Khoroshko ND; Frank GA
    Arkh Patol; 2003; 65(4):9-12. PubMed ID: 14518186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chronic myeloproliferative syndromes].
    de Ozalla CB; García Suárez J
    Rev Clin Esp; 1999 Apr; 199 Suppl 1():28-36. PubMed ID: 10422448
    [No Abstract]   [Full Text] [Related]  

  • 38. Gelatinous degeneration in a recipient of allogeneic bone marrow transplantation.
    Aisa Y; Mori T; Nakazato T; Yamazaki R; Ikeda Y; Okamoto S
    Int J Hematol; 2006 Dec; 84(5):465-7. PubMed ID: 17189232
    [No Abstract]   [Full Text] [Related]  

  • 39. Splenectomy for agnogenic myeloid metaplasia.
    Coon WW; Liepman MK
    Surg Gynecol Obstet; 1982 Apr; 154(4):561-3. PubMed ID: 7064091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of splenectomy in myelofibrosis with myeloid metaplasia.
    Barugola G; Cavallini A; Lipari G; Armatura G; Mantovani W; Baggio E
    Minerva Chir; 2010 Dec; 65(6):619-25. PubMed ID: 21224796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.